Home

ReShape Lifesciences, Inc. - Common Stock (RSLS)

2.4450
-1.7350 (-41.51%)
NASDAQ · Last Trade: Jun 9th, 10:51 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close4.180
Open2.430
Bid2.440
Ask2.450
Day's Range2.300 - 2.539
52 Week Range4.030 - 414.99
Volume1,039,750
Market Cap15.08M
PE Ratio (TTM)-0.7665
EPS (TTM)-3.2
Dividend & YieldN/A (N/A)
1 Month Average Volume3,054,265

Chart

About ReShape Lifesciences, Inc. - Common Stock (RSLS)

Reshape Lifesciences Inc is a biotechnology company focused on developing innovative medical technologies and solutions for weight management and obesity-related health issues. The company's primary aim is to enhance patient outcomes through its proprietary products, which include minimally invasive procedures designed to aid in weight loss and promote healthier lifestyles. By leveraging advanced engineering and clinical expertise, Reshape Lifesciences seeks to address the growing global health crisis associated with obesity and its complications, ultimately striving to empower individuals to take control of their health through effective interventions. Read More

News & Press Releases

Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · June 9, 2025
US Stocks Mixed; Motorcar Parts of America Posts Upbeat Earningsbenzinga.com
Via Benzinga · June 9, 2025
ReShape Lifesciences® Announces Pricing of $2.6 Million Public Offering
IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public offering of 1,054,604 shares of common stock at a public offering price of $2.50 per share. Gross proceeds from the offering are expected to be approximately $2.6 million before deducting placement agent fees and other offering expenses. The offering is expected to close on or about June 9, 2025, subject to the satisfaction of customary closing conditions.
By ReShape Lifesciences Inc · Via GlobeNewswire · June 9, 2025
What's going on in today's sessionchartmill.com
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via Chartmill · June 4, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · June 4, 2025
Which stocks are experiencing notable movement on Wednesday?chartmill.com
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · June 4, 2025
US Stocks Higher; Dollar Tree Shares Plunge After Q1 Earningsbenzinga.com
Via Benzinga · June 4, 2025
Wednesday's session: gap up and gap down stockschartmill.com
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · June 4, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 4, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · June 3, 2025
Wondering what's happening in today's after-hours session?chartmill.com
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · June 3, 2025
What's going on in today's sessionchartmill.com
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · June 3, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · June 3, 2025
Why ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surgebenzinga.com
ReShape Lifesciences gains MDR and UKCA certification for all EU and UK devices, meeting strict regulatory standards well before the 2027 deadline.
Via Benzinga · June 3, 2025
Which stocks are moving on Tuesday?chartmill.com
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · June 3, 2025
ReShape Lifesciences Stock Soars On Regulatory Certification For Medical Devices In EU, UK: Retail Eyes Fair Valuationstocktwits.com
ReShape CEO Paul F. Hickey said that the company achieved MDR and UKCA certification “well in advance” of the Dec. 31, 2027, regulatory deadline.
Via Stocktwits · June 3, 2025
Tuesday's session: gap up and gap down stockschartmill.com
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via Chartmill · June 3, 2025
ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio
IRVINE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Quality Management System (QMS) and entire commercial portfolio of medical devices sold in Europe and in the United Kingdom (UK) have been certified under the European Union (EU) Medical Device Regulation (MDR) (EU) 2017/745 and UK Conformity Assessment (UKCA), respectively.
By ReShape Lifesciences Inc · Via GlobeNewswire · June 3, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 2, 2025
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · June 2, 2025
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · May 30, 2025
Friday's after hours session: top gainers and loserschartmill.com
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · May 30, 2025
ReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update
Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys Progress Towards Completion
By ReShape Lifesciences Inc · Via GlobeNewswire · May 21, 2025
Orla Mining, ReShape Lifesciences And Other Big Stocks Moving Lower In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · May 12, 2025
Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · May 12, 2025